PerkinElmer Ventures
940 Winter Street, Waltham, MA, 02451, United States
Overview
PerkinElmer focused on improving the health and safety of people and the environment. Their innovative detection, imaging, informatics, and service capabilities, combined with deep market knowledge and expertise, help customers gain greater insights into their science to better protect their environment, their food supply, and the health of their families.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Hardware
- Health Care
Investment portfolio
- Virtue Diagnostics
Participated · Series B · Jan 2022
Virtue Diagnostics is a platform-based in vitro diagnostics (IVD) company focused on infectious disease, cancer, and chronic diseases. It provides affordable clinical solutions across all disease stages, including very early screening, initial diagnosis, treatment monitoring and minimal residual disease management. The company is led by CEO Johnson Zhang and is based in Singapore and Shanghai. Virtue's corporate and R&D headquarters are in Singapore, manufacturing is in Suzhou, China, and it operates a CRO/clinical lab in Beijing. In October 2022 the company raised $100M in a Series B to support its growth. Virtue intends to use the funds to bring its IVD products to selected emerging markets.